NCT03377478View on ClinicalTrials.gov

Expanding the Pool in Lung Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

September 21, 2021

Study Completion Date

April 1, 2022

Conditions
Hepatitis CLung Transplant
Interventions
DRUG

Epclusa

Patients testing positive for HCV viremia will receive 12 weeks of Epclusa.

Trial Locations (1)

15213

UPMC, Pittsburgh

All Listed Sponsors
lead

Pablo Sanchez

OTHER

NCT03377478 - Expanding the Pool in Lung Transplantation | Biotech Hunter | Biotech Hunter